Overview

Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness

Status:
COMPLETED
Trial end date:
2020-09-16
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy of MZ101 therapy in reducing liver stiffness.
Phase:
PHASE3
Details
Lead Sponsor:
Mezzion Pharma Co. Ltd
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
udenafil